ArticleHealth communication2015
Designing for dissemination: lessons in message design from "1-2-3 pap".
Article in Health communication, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Dissemination experiences and preferences from HIV service delivery organizations.Implementation science communications · 2025Article
- Improving dissemination products and practices for community-based organisations serving LGBTQ+ communities in the USA: a thematic analysis.BMJ public health · 2024Article
- Advancing healthcare equity through dissemination and implementation science.Health services research · 2023Review
- Dissemination and implementation research for oral and craniofacial health: Background, a review of literature and future directions.Community dentistry and oral epidemiology · 2023Review
- A Web-Based Decision Aid for Caregivers of Persons With Dementia With Firearm Access (Safe at Home Study): Protocol for a Randomized Controlled Trial.JMIR research protocols · 2023Article
- Developing criteria for research translation decision-making in community settings: a systematic review and thematic analysis informed by the Knowledge to Action Framework and community input.Implementation science communications · 2022Review
- Article
- Scale up mHealth HIV interventions: site and public health perspectives and lessons learned from P3.mHealth · 2021Review
- Evaluating a Technology-Mediated HPV Vaccination Awareness Intervention: A Controlled, Quasi-Experimental, Mixed Methods Study.Vaccines · 2020Article
- 'Lock to Live': development of a firearm storage decision aid to enhance lethal means counselling and prevent suicide.Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention · 2019Article
- Epidemiology and Implementation of Cancer Prevention in Disparate Populations and Settings.American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting · 2019Review
- An analysis of adaptations to multi-level intervention strategies to enhance implementation of clinical practice guidelines for treating tobacco use in dental care settings.Contemporary clinical trials communications · 2018Article
- A Social-Ecological Review of Cancer Disparities in Kentucky.Southern medical journal · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Despite a large number of evidence-based health communication interventions tested in private, public, and community health settings, there is a dearth of research on successful secondary dissemination of these interventions to other audiences. This article presents the case study of "1-2-3 Pap," a health communication intervention to improve human papillomavirus (HPV) vaccination uptake and Pap testing outcomes in Eastern Kentucky, and explores strategies used to disseminate this intervention to other populations in Kentucky, North Carolina, and West Virginia. Through this dissemination project, we identified several health communication intervention design considerations that facilitated our successful dissemination to these other audiences; these intervention design considerations include (a) developing strategies for reaching other potential audiences, (b) identifying intervention message adaptations that might be needed, and (c) determining the most appropriate means or channels by which to reach these potential future audiences. Using "1-2-3 Pap" as an illustrative case study, we describe how careful planning and partnership development early in the intervention development process can improve the potential success of enhancing the reach and effectiveness of an intervention to other audiences beyond the audience for whom the intervention messages were originally designed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.